Although we observed a decrease of LLC1 cancer cell proliferation in vitro upon treatment with GW0742, tumor growth and metastases formation in LLC1 cancer bearing animals was enhanced upon administration of the PPARβ/δ agonist. This evidence concerns the gene PPARD and neoplasm.